Medline (MDLN) Other Operating Expenses (2025 - 2026)

Medline (MDLN) reported Other Operating Expenses of -$15.0 million for Q1 2026, down 87.5% year-over-year from -$120.0 million in Q1 2025, and down 87.5% on a QoQ basis from -$8.0 million in Q1 2025.

Medline (MDLN) has 2 years of Other Operating Expenses data on file, last reported at -$15.0 million in Q1 2026.

  • Quarterly Other Operating Expenses fell 87.5% year-over-year to -$15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$23.0 million (changed N/A YoY) and the FY2025 annual result came in at -$78.0 million, down 110.81% from the prior year.
  • Other Operating Expenses retreated to -$15.0 million in Q1 2026 per MDLN's latest filing, from -$8.0 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at -$8.0 million in Q1 2025 and bottomed at -$15.0 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 146.28 Bn 141.88 Bn 1.83 Bn
2 Becton Dickinson 41.14 Bn 40.13 Bn 2.15 Bn
3 Medline 29.16 Bn 35.00 Bn 1.84 Bn
4 Resmed 27.13 Bn 25.47 Bn 890.98 Mn
5 West Pharmaceutical Services 22.71 Bn 22.19 Bn 296.40 Mn
6 Solventum 13.26 Bn 13.26 Bn 1.10 Bn
7 Align Technology 12.22 Bn 11.16 Bn 736.59 Mn
8 Cooper Companies 11.79 Bn 11.66 Bn 695.20 Mn
9 Baxter International 9.47 Bn 7.42 Bn 891.00 Mn
10 Aptargroup 7.19 Bn 6.99 Bn 351.91 Mn

Historic Data

Download Data 🔒
DateValue
Mar 28, 2026 -15.00 Mn
Mar 29, 2025 -8.00 Mn